Orale Anwendung; subkutane Anwendung; subkutane Anwendung; Salmonella Typhimurium-Mutante, genetisch stabil, doppelt attenuiert - search results

United States - English - NLM (National Library of Medicine)

oxsoralen-ultra- methoxsalen capsule, liquid filled

bausch health us, llc - methoxsalen (unii: u4vj29l7bq) (methoxsalen - unii:u4vj29l7bq) - methoxsalen 10 mg - photochemotherapy (methoxsalen with long-wave uva radiation) is indicated for the symptomatic control of severe, recalcitrant, disabling psoriasis not adequately responsive to other forms of therapy and when the diagnosis has been supported by biopsy. methoxsalen is intended to be administered only in conjunction with a schedule of controlled doses of long-wave ultraviolet radiation. a. patients exhibiting idiosyncratic reactions to psoralen compounds. b. patients possessing a specific history of light-sensitive disease states should not initiate methoxsalen therapy except under special circumstances. diseases associated with photosensitivity include lupus erythematosus, porphyria cutanea tarda, erythropoietic protoporphyria, variegate porphyria, xeroderma pigmentosum, and albinism. c. patients with melanoma or with a history of melanoma. d. patients with invasive squamous cell carcinomas. e. patients with aphakia because of the significantly increased risk of retinal damage due to the absence of lenses.

Israel - English - Ministry of Health

oxsoralen 20 mcgml

a.l. medi-market ltd. - methoxsalen - solution for blood fraction modification - methoxsalen 20 mcg / 1 ml - methoxsalen - oxsoralen is indicated in adults for extracorporeal use in the palliative treatment of advanced stage cutaneous t-cell lymphoma in patients who have not been responsive to other forms of treatment